Actively Recruiting

Phase Not Applicable
Age: 35Years +
FEMALE
NCT06636539

Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device

Led by Hologic, Inc. · Updated on 2025-10-22

75

Participants Needed

2

Research Sites

76 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a prospective, multi-center image case collection study to acquire de-identified contrast-enhanced breast images on a mammography device to support continuing software technology development. Eligible subjects include women at least 35 years old with a suspicious finding or breast abnormality on a screening or diagnostic mammogram who are indicated for a diagnostic exam or a biopsy procedure.

CONDITIONS

Official Title

Prospective Case Collection Study of Contrast-Enhanced Mammography Imaging Acquired on a New Investigational Device

Who Can Participate

Age: 35Years +
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female of any race and ethnicity
  • At least 35 years old
  • Has a suspicious finding or breast abnormality on a screening or diagnostic mammogram and is indicated for a diagnostic exam or biopsy
  • Able to read, understand, and sign the study-specific informed consent form
Not Eligible

You will not qualify if you...

  • Unable or unwilling to give informed consent or requires a legally authorized representative for consent
  • Has breast implants, cardiac pacemakers, nipple piercings, or IV ports in the mammography field of view on the breast of interest
  • Had an interventional procedure in the same breast as the suspicious finding within the last 6 months
  • Pregnant or presumed pregnant
  • Breastfeeding
  • Actively receiving chemotherapy for any cancer
  • At risk of complications from iodinated contrast agent, including renal insufficiency or being on dialysis
  • Known allergy to iodinated contrast
  • Known allergy to gadolinium contrast agents
  • At increased risk for complications related to renal function, anticoagulant therapy, or bleeding disorders based on physician judgment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Solis Mammography Memorial Village

Houston, Texas, United States, 77024

Active, Not Recruiting

2

Washington Radiology Sterling

Sterling, Virginia, United States, 20166

Actively Recruiting

Loading map...

Research Team

M

Muhammad Waqas Director of Global Clinical Affairs

CONTACT

A

Alexis Cooper Senior Manager, Clinical Development-Clinical Affairs

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

SCREENING

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here